✦ LIBER ✦

P.29 Low molecular heparins in prophylaxis of recurrent placental abruptions

✍ Scribed by O. Panfilova; N. Makatsaria; M. Kiria

Book ID: 117258415
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 40 KB
Volume: 127
Category: Article
ISSN: 0049-3848
DOI: 10.1016/s0049-3848(11)70084-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-060 Prophylaxis of recurrent placental

P-060 Prophylaxis of recurrent placental abruptions in multiple pregnancy

✍ Panfilova, O.; Makatsariya, N. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Low-molecular-weight heparins in prophyl

Low-molecular-weight heparins in prophylaxis and therapy of thromboembolic diseases

✍ DeLoughery, Thomas 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 107 KB

P.53 Use of low molecular-weight heparin

P.53 Use of low molecular-weight heparin and natural progesterone for the prevention of recurrent pregnancy complications (pre-eclampsia, pregnancy loss, placental abruption) in women with metabolic syndrome

✍ T.B. Radulovich; E.B. Perederyaeva; A.D. Makatsaria 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Low-dose heparin to low molecular weight

Low-dose heparin to low molecular weight heparin prophylaxis: in pursuit of excellence – a personal perspective

✍ V. V. Kakkar 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

Placental transport of low molecular wei

Placental transport of low molecular weight heparin in the pregnant sheep

✍ M. Andrew; B. Boneu; J. Cade; A. L. Cerskus; J. Hirsh; A. Jefferies; M. E. Towel 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Heparin/dihydroergotamine for venous thr

Heparin/dihydroergotamine for venous thrombosis prophylaxis: comparison of low-dose heparin and low molecular weight heparin in hip surgery

✍ Dr. M. R. Lassen; L. C. Borris; H. M. Christiansen; F. Møller-Larsen; V. E. Knud 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 2 views

Abstract In a prospective, double-blind controlled study we have compared the prophylactic efficacy against deep vein thrombosis of low-dose heparin + dihydroergotamine (A), low molecular weight heparin + dihydro-ergotamine (B) and placebo (C). A total of three hundred and fifty-six patients undergo